VenoStent is a superior bioengineered vascular support company dedicated to saving and improving the lives of vascular surgery patients. As a clinical-stage tissue engineering company, we have developed innovative tunable, bioabsorbable smart polymer wraps that have the potential to transform the field of vascular surgery. Our primary focus is on developing a perivascular wrap called SelfWrap, specifically designed to enhance the quality and length of life for dialysis patients worldwide.

Unlike alloy-based products, our bioabsorbable materials are easily absorbed by the body. Additionally, our smart materials provide a personalized, custom fit for each patient, ensuring optimum performance and comfort. With the use of 3D-printed polymers, our wraps are reliably and robustly produced, meeting the highest standards of quality.

Our technology has countless applications, including coronary and peripheral bypass grafting, among others. We have assembled a cross-disciplinary team of experts, ranging from scientists and engineers to quality and product development managers, ensuring our commitment to excellence. VenoStent is making significant strides in the field, receiving breakthrough device designation from the FDA and completing a $16M series A financing.

We are embarking on clinical trials to improve the success rate of vascular surgery outcomes. Please note that our SelfWrap device is currently in the research and development phase and is not available for sale in any country. Contact us at info@venostent.

com for more information